John Y. Caloz
2015
In 2015, John Y. Caloz earned a total compensation of $987.9K as Chief Financial Officer and Treasurer at CytRx, a 32% increase compared to previous year.
Compensation breakdown
| Bonus | $135,000 |
|---|---|
| Option Awards | $477,900 |
| Salary | $375,000 |
| Total | $987,900 |
Caloz received $477.9K in option awards, accounting for 48% of the total pay in 2015.
Caloz also received $135K in bonus and $375K in salary.
Rankings
In 2015, John Y. Caloz's compensation ranked 8,006th out of 13,638 executives tracked by ExecPay. In other words, Caloz earned more than 41.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,006 out of 13,638 | 41st |
Division Manufacturing | 3,052 out of 5,190 | 41st |
Major group Chemicals And Allied Products | 1,100 out of 1,854 | 41st |
Industry group Drugs | 887 out of 1,528 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 153 out of 254 | 40th |
Source: SEC filing on May 20, 2016.
Caloz's colleagues
We found four more compensation records of executives who worked with John Y. Caloz at CytRx in 2015.
News
CytRx CEO Stephen Snowdy's 2023 pay slips 3% to $545K
August 20, 2024
CytRx CEO Stephen Snowdy receives $563K in 2022
July 28, 2023
CytRx CEO Steven Kriegsman's 2021 pay jumps 592% to $7M
June 16, 2022
CytRx CEO Steven Kriegsman's 2020 pay falls 41% to $1M
June 14, 2021
CytRx CEO Steven Kriegsman's 2019 pay jumps 68% to $1.7M
June 12, 2020
CytRx CEO Steven Kriegsman's 2018 pay falls 48% to $1M
June 26, 2019